Trial · NCT01466686
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Pulmonary Embolism | Respiratory, thoracic and mediastinal disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Death (Disease Progression) | General disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 19 | 30 | |
| serious | Death (NOS) | General disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 4 | 30 | |
| serious | Aphasia | Nervous system disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Disease Progression | General disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 6 | 30 | |
| serious | Fatigue | General disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Intraparenchymal Hemorrhage of Brain | Nervous system disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Lymphocyte Count Decrease | Investigations | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Personality/Behavioral CTC | Psychiatric disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | ALT increased | Investigations | Temozolomide With Low Dose Fractionated Radiation Therapy | 2 | 30 | |
| serious | Ambulatory Dysfunction / Inability to Walk | Nervous system disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 2 | 30 | |
| serious | Aphasia | Nervous system disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Bowel Incontinence | Gastrointestinal disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Cognitive Disturbance | Psychiatric disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 3 | 30 | |
| serious | Disease Progression | General disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 4 | 30 | |
| serious | DVT (NOS) | Vascular disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 2 | 30 | |
| serious | DVT (RLE) | Vascular disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Fatigue | General disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 3 | 30 | |
| serious | Headache | Nervous system disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 1 | 30 | |
| serious | Hyperglycemia / Elevated Glucose | Metabolism and nutrition disorders | Temozolomide With Low Dose Fractionated Radiation Therapy | 2 | 30 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01466686/events